The RAPS Nominating Committee is charged with selecting a slate based on professional experience, substantive involvement with RAPS, and a clearly articulated vision for expanding the global reach of the organization and advancing the regulatory profession.
The committee has selected a distinguished group of members to serve on the Board of Directors from 2010–2012. These individuals have the knowledge, visibility, depth and breadth of experience, and commitment necessary to serve the organization well into the future. We are very encouraged by these regulatory professionals who are so enthusiastic and eager to serve in such an important leadership capacity.
The following individuals have been approved by RAPS' membership and will begin their terms on 1 January 2010:
President-elect:
Cecilia Kimberlin, PhD, RAC
vice president, QA/RA/medical affairs, medical products
Abbott Laboratories
Libertyville, Illinois
Directors:
Linda Bowen, MS, RAC
director, regulatory intelligence–US Region
sanofi-aventis
Bridgewater, New Jersey
Daniel Mannix, PhD
group director, oncology
Bristol Myers Squibb International
Belgium
Susumu Nozawa, RAC
director, corporate regulatory affairs/Japan region
Becton, Dickinson and Company
Franklin Lakes, New Jersey